دانلود کتاب سلول های بنیادی در پزشکی ترمیمی: علم، مقررات و استراتژی تجاری
Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies, 1ed

Stem cells, as therapeutic agents or as research or diagnostics tools, represent an emerging technology with a transformational potential that parallels the paradigm shift operated by the development of monoclonal antibodies in the 1990s, or even the coming of age of genetic engineering technology platforms in the 1980s. Those working with stem cell technologies face a complex matrix of ethical, regulatory, policy, logistics, supply chain, manufacturing, pricing and reimbursement challenges.

This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the science, business, legal, and financing fundamentals of stem cell technologies, offering a holistic assessment of this emerging and dynamic segment of the field of regenerative medicine.

  • Reviews the very latest advances in the technology and business of stem cells used for therapy, research, and diagnostics
  • Identifies key challenges to the commercialisation of stem cell technology and avenues to overcome problems in the pipeline
  • Written by an expert team with extensive experience in the business, basic and applied science of stem cell research

This comprehensive volume is essential reading for researchers in cell biology, biotechnology, regenerative medicine, and tissue engineering, including scientists and professionals, looking to enter commercial biotechnology fields. It is valuable for R&D staff in academia, biotechnology and pharmaceutical companies, and professionals from consulting firms, regulatory agencies, and patenting offices, also to business and scientific managers, venture capitalists, business development professionals, corporate strategists, policy makers, patient advocates, and healthcare payers. It also constitutes a useful resource as a textbook to support science and business students looking into courses in the field of regenerative medicine.

About the Author

Alain A. Vertès, London Business School, London, UK

Nasib Qureshi, United States Department of Agriculture (ARS), National Center for Agricultural
Utilization Research, Illinois, USA

Arnold I. Caplan, Case Western Reserve University, Ohio, USA

Lee Babiss, Pharmaceutical Product Development, North Carolina, USA

Contents

۱ Therapeutic stem cells answer a strategic breakthrough need of healthcare
۲ Ethical considerations on the research and business of stem cells
۳ Projected growth of the world-wide stem cell market
۴ Cell therapy manufacturing: identifying and meeting demand
۵ The history of stem cell transplantation
۶ Regulatory and intellectual property considerations for therapeutic human stem cell-based regenerative medicine product development: a US perspective
۷ The regulation of stem cells in the UK and the EU
۸ The business of stem cell research tools
۹ Stem cell-derived cardiomyocytes and hepatocytes as tools for drug development and screening applications
۱۰ Stem cell tools for compound development
۱۱ Stem cell origin of cancer: prospects for functional therapeutics and regenerative medicine
۱۲ The market for stem cell medicines for domestic and high value animals
۱۳ Stem cells in veterinary medicine: a conceptual approach
۱۴ Stem cell veterinary medicines: a practical approach
۱۵ Stem cell veterinary medicines as signs pointing towards successful human stem cell therapeutics
۱۶ Animal models in regenerative medicine
۱۷ Stem cell characterisation: a guide to stem cell types technologies and future applications
۱۸ Stem cell value chains
۱۹ Stem cell culture processes
۲۰ Indication transformation maps and the challenge of live cell delivery
۲۱ Delivery and targeting of therapeutic cells
۲۲ Hematopoietics stem cells
۲۳ MSCs: the new medicine
۲۴ Innovation and commercialisation of induced pluripotent stem cells
۲۵ Embryonic stem cells
۲۶ Allogeneic versus autologous stem cell transplantation in regenerative medicine
۲۷ Immunological barriers to regenerative medicine: do they matter?
۲۸ Challenges in the clinical development of stem cells
۲۹ Pricing and reimbursement of regenerative medicines
۳۰ The role of patient advocacy in the clinical translation of regenerative medicine
۳۱ Financing strategies for regenerative medicine start-ups
۳۲ Strategic alliances mergers and acquisitions in regenerative medicine
۳۳ History of monoclonal antibodies and lessons for the development of stem cell therapeutics
۳۴ Deployment of stem cell technologies in industry and healthcare

قیمت : 3000 تومان

لینک کوتاه : https://bookbaz.ir/?p=54299
نویسنده : Alain A. Vertes , Nasib Qureshi
ناشر : Wiley-Blackwell; 1 edition
سال انتشار : 2015
زبان کتاب : انگلیسی
نوع فایل : PDF
تعداد صفحات : 761
(ISBN) شابک : 111997139X
قیمت کتاب درآمازون : $190.00
حجم فایل : 13 MB

51d0j8w45WL._SX380_BO1,204,203,200_

۳۰۰۰ تـومان – خرید